We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $114B Turnover 39.06%
1-Year Est. Return 35.47%
 

Marshall Wace is a British firm that runs long/short hedge funds. Its strategies combine computer-driven and traditional company analysis, applied worldwide and mostly to long/short equity. Paul Marshall, formerly head of European equities at Mercury Asset Management, and Ian Wace, formerly head of equities trading at Deutsche Bank, founded it in 1997. In 2002 it launched TOPS, a system that gathers investment ideas from equity professionals and uses algorithms to turn them into stock portfolios. In 2015 Marshall Wace formed a long-term partnership with KKR, a private equity and credit investor that took an ownership interest in the firm.

This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+35.47%
3 Year Est. Return
+152.69%
5 Year Est. Return
+193.17%
10 Year Est. Return
+740.37%
AUM
$12.2B
AUM Growth
+$1.52B
Cap. Flow
+$931M
Cap. Flow %
7.66%
Top 10 Hldgs %
19.97%
Holding
2,125
New
431
Increased
455
Reduced
370
Closed
829
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.7 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.7 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$197M
2
BABA icon
Alibaba
BABA
+$190M
3
AMZN icon
Amazon
AMZN
+$161M
4
GDDY icon
GoDaddy
GDDY
+$135M
5
DIS icon
Walt Disney
DIS
+$132M

Sector Composition

Rank Sector Weight
1 Healthcare 25.83%
2 Consumer Discretionary 24.03%
3 Technology 11.35%
4 Financials 8.48%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BSX icon
1
Boston Scientific
BSX
$60.8B
$410M 3.38%
9,545,382
+5,131,591
+116% +$197M
2016 Q1
13 quarters
TMO icon
2
Thermo Fisher Scientific
TMO
$248B
$317M 2.61%
1,081,081
+305,978
+39% +$84.3M
2018 Q4
2 quarters
AMZN icon
3
Amazon
AMZN
$2.67T
$303M 2.49%
3,202,440
+1,733,420
+118% +$161M
2013 Q2
24 quarters
ZTS icon
4
Zoetis
ZTS
$32.1B
$273M 2.25%
2,407,075
-919,152
-28% -$96.3M
2013 Q2
24 quarters
TFX icon
5
Teleflex
TFX
$6.41B
$250M 2.06%
756,383
+159,606
+27% +$48.2M
2016 Q4
10 quarters
MCD icon
6
McDonald's
MCD
$193B
$245M 2.02%
1,179,670
-272,290
-19% -$53.9M
2016 Q3
11 quarters
BABA icon
7
Alibaba
BABA
$202B
$210M 1.73%
1,237,298
+1,102,340
+817% +$190M
2015 Q2
16 quarters
DIS icon
8
Walt Disney
DIS
$202B
$163M 1.34%
1,168,468
+994,529
+572% +$132M
2018 Q4
2 quarters
GDDY icon
9
GoDaddy
GDDY
$12.1B
$132M 1.08%
1,878,596
+1,788,699
+1,990% +$135M
2015 Q4
14 quarters
EBAY icon
10
eBay
EBAY
$50.7B
$123M 1.01%
3,104,213
+974,814
+46% +$36.6M
2019 Q1
1 quarter
FIS icon
11
Fidelity National Information Services
FIS
$13.3B
$112M 0.92%
910,941
+405,440
+80% +$47.6M
2019 Q1
1 quarter
STLA icon
12
Stellantis
STLA
$9.7B
$100M 0.82%
7,159,497
+4,946,622
+224% +$71.8M
2018 Q2
4 quarters
BFAM icon
13
Bright Horizons
BFAM
$2.4B
$100M 0.82%
661,981
-43,533
-6% -$5.84M
2018 Q3
3 quarters
AZN icon
14
AstraZeneca
AZN
$270B
$96.8M 0.8%
1,172,705
+848,612
+262% +$66.5M
2019 Q1
1 quarter
INTU icon
15
Intuit
INTU
$72.3B
$95.7M 0.79%
366,164
+239,030
+188% +$60.7M
2018 Q2
4 quarters
RL icon
16
Ralph Lauren
RL
$21.7B
$87.3M 0.72%
768,624
+33,187
+5% +$3.98M
2018 Q4
2 quarters
EPAM icon
17
EPAM Systems
EPAM
$7.82B
$83.6M 0.69%
+482,974
New +$83.2M
2019 Q2
0 quarters
SPGI icon
18
S&P Global
SPGI
$127B
$74.6M 0.61%
327,480
+28,177
+9% +$6.15M
2016 Q2
12 quarters
LULU icon
19
lululemon athletica
LULU
$11.9B
$73.8M 0.61%
409,638
+185,940
+83% +$32.3M
2017 Q2
8 quarters
HLT icon
20
Hilton
HLT
$79.3B
$68.8M 0.57%
703,910
+279,477
+66% +$25.4M
2018 Q2
4 quarters
IDXX icon
21
Idexx Laboratories
IDXX
$53.3B
$67.5M 0.56%
245,280
-15,996
-6% -$3.94M
2018 Q2
4 quarters
OLLI icon
22
Ollie's Bargain Outlet
OLLI
$5.35B
$66.5M 0.55%
763,500
+192,961
+34% +$18.2M
2018 Q1
5 quarters
DG icon
23
Dollar General
DG
$28.8B
$66.5M 0.55%
491,927
+125,620
+34% +$15.9M
2017 Q4
6 quarters
G icon
24
Genpact
G
$6.94B
$64.3M 0.53%
1,689,255
+424,264
+34% +$15.4M
2018 Q3
3 quarters
TXRH icon
25
Texas Roadhouse
TXRH
$11.7B
$63.5M 0.52%
1,182,711
+564,897
+91% +$31.8M
2017 Q4
6 quarters

Similar funds

Marshall Wace's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace held 2,125 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace deployed $931M of net new capital in Q2 2019, opening 431 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.

  • Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
  • Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
  • Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
  • Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
  • Marshall Wace opened 431 new positions and closed 829 in Q2 2019.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.

Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.